4.6 Article

Vascular endothelial growth factor receptor-3 regulates astroglial glutamate transporter-1 expression viamTORactivation in reactive astrocytes following pilocarpine-induced status epilepticus

Journal

GLIA
Volume 69, Issue 2, Pages 296-309

Publisher

WILEY
DOI: 10.1002/glia.23897

Keywords

glutamate transporter-1; mammalian target of rapamycin; reactive astrocytes; status epilepticus; vascular endothelial growth factor receptor-3

Categories

Funding

  1. Ministry of Education [NRF-2018R1D1A1B07046708, NRF-2018R1D1A1B07047059]
  2. National Research Foundation of Korea

Ask authors/readers for more resources

The study reveals that VEGFR-3-mediated mTOR activation may contribute to regulating GLT-1 expression in reactive astrocytes during the subacute phase of epilepsy. Upregulation of VEGFR-3 in reactive astrocytes may play a role in preventing hyperexcitability induced by continued seizure activity.
Recent evidence has shown that the vascular endothelial growth factor (VEGF) system plays a crucial role in several neuropathological processes. We previously reported an upregulation of VEGF-C and its receptor, VEGFR-3, in reactive astrocytes after the onset of status epilepticus (SE). However, it remains unknown, which molecules act as downstream signals following VEGFR-3 upregulation, and are involved in reactive astrogliosis after SE. Therefore, we investigated whether VEGFR-3 upregulation within reactive astrocytes is associated with the activation of mammalian target of rapamycin (mTOR) signaling, which we confirmed by assaying for the phosphorylated form of S6 protein (pS6), and whether VEGFR-3-mediated mTOR activation induces astroglial glutamate transporter-1 (GLT-1) expression in the hippocampus after pilocarpine-induced SE. We found that spatiotemporal expression of pS6 was consistent with VEGFR-3 expression in the hippocampus after SE, and that both pS6 and VEGFR-3 were highly expressed in SE-induced reactive astrocytes. Treatment with the mTOR inhibitor rapamycin decreased astroglial VEGFR-3 expression and GLT-1 expression after SE. Treatment with a selective inhibitor for VEGFR-3 attenuated astroglial pS6 expression as well as suppressed GLT-1 expression and astroglial reactivity in the hippocampus after SE. These findings demonstrate that VEGFR-3-mediated mTOR activation could contribute to the regulation of GLT-1 expression in reactive astrocytes during the subacute phase of epilepsy. In conclusion, the present study suggests that VEGFR-3 upregulation in reactive astrocytes may play a role in preventing hyperexcitability induced by continued seizure activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available